Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis.
Phase of Trial: Phase II
Latest Information Update: 27 May 2011
At a glance
- Drugs Rezatomidine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 27 May 2011 Planned end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 26 Jun 2007 Status changed from recruiting to discontinued.
- 13 Nov 2006 New trial record.